Unleashing CAR-T cell therapy to destroy solid tumors in thyroid cancer
Mayo Clinic researchers will jump four hurdles to apply chimeric antigen receptor-T cell therapy (CAR-T cell therapy) to solid tumors in thyroid cancer. This regenerative immunotherapy has shown promising results in blood cancers, and new research is focused on using this treatment on more types of malignancies. "CAR-T cell therapy is unlike other therapeutics," says Saad Kenderian, M.B., Ch.B., a hematologist and cancer researcher. "Other therapies may slow down cancer. CAR-T cell therapy has shown…
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
More News: Cancer | Cancer & Oncology | Databases & Libraries | Hematology | Immunotherapy | Thyroid | Thyroid Cancer